United States - Re-Export of Alkaloids Not in Dosage Forms
Since 2014, United States Re-Export of Alkaloids Not in Dosage Forms jumped by 182.7% year on year. In 2019, the country was number 1 among other countries in Re-Export of Alkaloids Not in Dosage Forms at $465,437. Guyana, United Arab Emirates and New Zealand respectively ranked number 2, 3 and 4 in this ranking. United States recorded the best 5 years average growth at +182.7% per year, while United Arab Emirates witnessed the worst performance at -56.8% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 465,437.00 |
| 2018 | 340,915.00 |
| 2017 | 849,355.00 |
| 2016 | 87,247.00 |
| 2015 | 76,342.00 |
Download all data from 1991 to 2019
How does United States rank in Re-Export of Alkaloids Not in Dosage Forms?
| # | 5 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
465,437.00 | 2019 | +36.5 % | +182.7 % | View data |
| 2 |
#2
Guyana
|
128,391.00 | 2014 | +1,833.9 % | +54.5 % | View data |
| 3 |
#3
United Arab Emirates
|
8,794.32 | 2018 | NA | -56.8 % | View data |
| 4 |
#4
New Zealand
|
83.84 | 2018 | NA | -48.7 % | View data |
| 5 |
#5
Jamaica
|
51.00 | 2016 | NA | NA | View data |